Is ventricular tachycardia radiofrequency ablation safe in NYHA IV heart failure patients, and does elimination of recurrent VT improve mortality?
VT radiofrequency ablation is safe in NYHA IV heart failure patients, and successful elimination of VT may significantly improve survival in this high-risk population.
Despite greater baseline comorbidities, VT radiofrequency ablation can be safely performed among NYHA IV patients. Early VT recurrence is significantly associated with subsequent mortality regardless of NYHA status. Elimination of recurrent VT in NYHA IV patients may reduce mortality to a level comparable to NYHA II and III with arrhythmia recurrence.
Tzou et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: